{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:03:14Z","timestamp":1792843394867,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI143714"],"award-info":[{"award-number":["AI143714"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI070285"],"award-info":[{"award-number":["AI070285"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2210520"],"award-info":[{"award-number":["W81XWH2210520"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The proteasome of the malaria parasite <jats:italic>Plasmodium falciparum<\/jats:italic> (Pf20S) is an advantageous drug target because its inhibition kills <jats:italic>P. falciparum<\/jats:italic> in multiple stages of its life cycle and synergizes with artemisinins. We recently developed a macrocyclic peptide, TDI-8304, that is highly selective for Pf20S over human proteasomes and is potent in vitro and in vivo against <jats:italic>P. falciparum<\/jats:italic>. A mutation in the Pf20S \u03b26 subunit, A117D, confers resistance to TDI-8304, yet enhances both enzyme inhibition and anti-parasite activity of a tripeptide vinyl sulfone \u03b22 inhibitor, WLW-vs. Here we present the high-resolution cryo-EM structures of Pf20S with TDI-8304, of human constitutive proteasome with TDI-8304, and of Pf20S\u03b26<jats:sup>A117D<\/jats:sup> with WLW-vs that give insights into the species selectivity of TDI-8304, resistance to it, and the collateral sensitivity associated with resistance, including that TDI-8304 binds \u03b22 and \u03b25 in wild type Pf20S as well as WLW-vs binds \u03b22 and \u03b25 in Pf20S\u03b26<jats:sup>A117D<\/jats:sup>. We further show that TDI-8304 kills <jats:italic>P. falciparum<\/jats:italic> as quickly as chloroquine and artemisinin and is active against <jats:italic>P. cynomolgi<\/jats:italic> at the liver stage. This increases interest in using these structures to facilitate the development of Pf20S inhibitors that target multiple proteasome subunits and limit the emergence of resistance.<\/jats:p>","DOI":"10.1038\/s41467-023-44077-2","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T10:01:53Z","timestamp":1702548113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-5105","authenticated-orcid":false,"given":"Hao-Chi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-3339","authenticated-orcid":false,"given":"Daqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7095-7081","authenticated-orcid":false,"given":"Wenhu","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2353-2162","authenticated-orcid":false,"given":"Jianxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benigno","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-2882","authenticated-orcid":false,"given":"Francisco-Javier","family":"Gamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1974","authenticated-orcid":false,"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-3485","authenticated-orcid":false,"given":"Alison","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Kirkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8085-8928","authenticated-orcid":false,"given":"Huilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-7073","authenticated-orcid":false,"given":"Gang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"44077_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-3305-3-5","volume":"3","author":"FE Cox","year":"2010","unstructured":"Cox, F. E. History of the discovery of the malaria parasites and their vectors. Parasit. Vectors 3, 5 (2010).","journal-title":"Parasit. Vectors"},{"key":"44077_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","volume":"37","author":"M Duffey","year":"2021","unstructured":"Duffey, M. et al. Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends Parasitol. 37, 709\u2013721 (2021).","journal-title":"Trends Parasitol."},{"key":"44077_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht, K. J., Mok, S. & Fidock, D. A. Molecular mechanisms of drug resistance in Plasmodium falciparum malaria. Annu. Rev. Microbiol 74, 431\u2013454 (2020).","journal-title":"Annu. Rev. Microbiol"},{"key":"44077_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar, K., Bhattacharjee, S. & Safeukui, I. Drug resistance in Plasmodium. Nat. Rev. Microbiol. 16, 156\u2013170 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"44077_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga, C. et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u2013365 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"44077_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411\u2013423 (2014).","journal-title":"N. Engl. J. Med."},{"key":"44077_CR7","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/S0140-6736(12)60488-7","volume":"379","author":"AC Uhlemann","year":"2012","unstructured":"Uhlemann, A. C. & Fidock, D. A. Loss of malarial susceptibility to artemisinin in Thailand. Lancet 379, 1928\u20131930 (2012).","journal-title":"Lancet"},{"key":"44077_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385, 1163\u20131171 (2021).","journal-title":"N. Engl. J. Med."},{"key":"44077_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","volume":"64","author":"JF Trape","year":"2001","unstructured":"Trape, J. F. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med Hyg. 64, 12\u201317 (2001).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"44077_CR10","doi-asserted-by":"publisher","first-page":"e1010058","DOI":"10.1371\/journal.ppat.1010058","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang, H. & Lin, G. Microbial proteasomes as drug targets. PLoS Pathog. 17, e1010058 (2021).","journal-title":"PLoS Pathog."},{"key":"44077_CR11","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1073\/pnas.1820175116","volume":"116","author":"S Wyllie","year":"2019","unstructured":"Wyllie, S. et al. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition. Proc. Natl Acad. Sci. USA 116, 9318\u20139323 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44077_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","volume":"537","author":"S Khare","year":"2016","unstructured":"Khare, S. et al. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537, 229\u2013233 (2016).","journal-title":"Nature"},{"key":"44077_CR13","doi-asserted-by":"publisher","first-page":"e1007722","DOI":"10.1371\/journal.ppat.1007722","volume":"15","author":"BH Stokes","year":"2019","unstructured":"Stokes, B. H. et al. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents. PLoS Pathog. 15, e1007722 (2019).","journal-title":"PLoS Pathog."},{"key":"44077_CR14","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1021\/jacs.8b06656","volume":"140","author":"E Yoo","year":"2018","unstructured":"Yoo, E. et al. Defining the determinants of specificity of Plasmodium proteasome inhibitors. J. Am. Chem. Soc. 140, 11424\u201311437 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"44077_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature16936","volume":"530","author":"H Li","year":"2016","unstructured":"Li, H. et al. Structure- and function-based design of Plasmodium-selective proteasome inhibitors. Nature 530, 233\u2013236 (2016).","journal-title":"Nature"},{"key":"44077_CR16","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.1002\/anie.202015845","volume":"60","author":"W Zhan","year":"2021","unstructured":"Zhan, W. et al. Development of a highly selective Plasmodium falciparum proteasome inhibitor with anti-malaria activity in humanized mice. Angew. Chem. Int. Ed. Engl. 60, 9279\u20139283 (2021).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"44077_CR17","unstructured":"Xie, S. C. et al. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proc. Natl Acad. Sci. USA 118, e2107213118 (2021)."},{"key":"44077_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.chembiol.2023.03.002","volume":"30","author":"I Deni","year":"2023","unstructured":"Deni, I. et al. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome. Cell Chem. Biol. 30, 470\u2013485.e6 (2023).","journal-title":"Cell Chem. Biol."},{"key":"44077_CR19","doi-asserted-by":"publisher","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","volume":"115","author":"LA Kirkman","year":"2018","unstructured":"Kirkman, L. A. et al. Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance. Proc. Natl Acad. Sci. USA 115, E6863\u2013E6870 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44077_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/acsinfecdis.9b00527","volume":"6","author":"MR Rosenthal","year":"2020","unstructured":"Rosenthal, M. R. & Ng, C. L. Plasmodium falciparum Artemisinin resistance: the effect of heme, protein damage, and parasite cell stress response. ACS Infect. Dis. 6, 1599\u20131614 (2020).","journal-title":"ACS Infect. Dis."},{"key":"44077_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.pt.2020.07.004","volume":"36","author":"DS Khoury","year":"2020","unstructured":"Khoury, D. S., Cao, P., Zaloumis, S. G. & Davenport, M. P. Interdisciplinary approaches to Malaria, C. artemisinin resistance and the unique selection pressure of a short-acting antimalarial. Trends Parasitol. 36, 884\u2013887 (2020).","journal-title":"Trends Parasitol."},{"key":"44077_CR22","doi-asserted-by":"publisher","first-page":"e1008482","DOI":"10.1371\/journal.ppat.1008482","volume":"16","author":"NF Gnadig","year":"2020","unstructured":"Gnadig, N. F. et al. Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13. PLoS Pathog. 16, e1008482 (2020).","journal-title":"PLoS Pathog."},{"key":"44077_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer, J. et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347, 428\u2013431 (2015).","journal-title":"Science"},{"key":"44077_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1021\/acsinfecdis.0c00900","volume":"7","author":"MR Rosenthal","year":"2021","unstructured":"Rosenthal, M. R. & Ng, C. L. A proteasome mutation sensitizes P. falciparum Cam3.II K13(C580Y) parasites to DHA and OZ439. ACS Infect. Dis. 7, 1923\u20131931 (2021).","journal-title":"ACS Infect. Dis."},{"key":"44077_CR25","doi-asserted-by":"publisher","first-page":"e00741","DOI":"10.1128\/AAC.00741-20","volume":"64","author":"P Vanachayangkul","year":"2020","unstructured":"Vanachayangkul, P. et al. Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver stage of Plasmodium cynomolgi infection in Rhesus Macaques. Antimicrob. Agents Chemother. 64, e00741 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"44077_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04221-9","volume":"9","author":"A Roth","year":"2018","unstructured":"Roth, A. et al. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat. Commun. 9, 1837 (2018).","journal-title":"Nat. Commun."},{"key":"44077_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/bdd.2020","volume":"37","author":"A Watanabe","year":"2016","unstructured":"Watanabe, A., Mayumi, K., Nishimura, K. & Osaki, H. In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice. Biopharm. Drug Dispos. 37, 373\u2013378 (2016).","journal-title":"Biopharm. Drug Dispos."},{"key":"44077_CR28","doi-asserted-by":"publisher","first-page":"e1003488","DOI":"10.1371\/journal.ppat.1003488","volume":"9","author":"V Muralidharan","year":"2013","unstructured":"Muralidharan, V. & Goldberg, D. E. Asparagine repeats in Plasmodium falciparum proteins: good for nothing? PLoS Pathog. 9, e1003488 (2013).","journal-title":"PLoS Pathog."},{"key":"44077_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.aaf8993","volume":"353","author":"J Schrader","year":"2016","unstructured":"Schrader, J. et al. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design. Science 353, 594\u2013598 (2016).","journal-title":"Science"},{"key":"44077_CR30","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-21-0005","volume":"20","author":"MP Sanderson","year":"2021","unstructured":"Sanderson, M. P. et al. M3258 is a selective inhibitor of the immunoproteasome subunit LMP7 (beta5i) delivering efficacy in multiple myeloma models. Mol. Cancer Ther. 20, 1378\u20131387 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"44077_CR31","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1021\/acs.jmedchem.1c00047","volume":"64","author":"M Thomas","year":"2021","unstructured":"Thomas, M. et al. Scaffold-hopping strategy on a series of proteasome inhibitors led to a preclinical candidate for the treatment of visceral leishmaniasis. J. Med. Chem. 64, 5905\u20135930 (2021).","journal-title":"J. Med. Chem."},{"key":"44077_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chembiol.2023.04.006","volume":"30","author":"W Zhan","year":"2023","unstructured":"Zhan, W. et al. Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance. Cell Chem. Biol. 30, 457\u2013469.e411 (2023).","journal-title":"Cell Chem. Biol."},{"key":"44077_CR33","unstructured":"Guide for the Care and Use of Laboratory Animals Eighth Edition, (Washington D.C., 2011)."},{"key":"44077_CR34","doi-asserted-by":"publisher","first-page":"119221","DOI":"10.1016\/j.biomaterials.2019.05.032","volume":"216","author":"ACY Chua","year":"2019","unstructured":"Chua, A. C. Y. et al. Hepatic spheroids used as an in vitro model to study malaria relapse. Biomaterials 216, 119221 (2019).","journal-title":"Biomaterials"},{"key":"44077_CR35","doi-asserted-by":"publisher","first-page":"e43362","DOI":"10.7554\/eLife.43362","volume":"8","author":"DK Gupta","year":"2019","unstructured":"Gupta, D. K. et al. The Plasmodium liver-specific protein 2 (LISP2) is an early marker of liver stage development. Elife 8, e43362 (2019).","journal-title":"Elife"},{"key":"44077_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.chom.2018.01.002","volume":"23","author":"N Gural","year":"2018","unstructured":"Gural, N. et al. In vitro culture, drug sensitivity, and transcriptome of Plasmodium vivax hypnozoites. Cell Host Microbe 23, 395\u2013406 e394 (2018).","journal-title":"Cell Host Microbe"},{"key":"44077_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0962-2","volume":"14","author":"M Linares","year":"2015","unstructured":"Linares, M. et al. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay. Malar. J. 14, 441 (2015).","journal-title":"Malar. J."},{"key":"44077_CR38","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).","journal-title":"Elife"},{"key":"44077_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"44077_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"44077_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"44077_CR42","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41564-019-0524-4","volume":"4","author":"SC Xie","year":"2019","unstructured":"Xie, S. C. et al. The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis. Nat. Microbiol. 4, 1990\u20132000 (2019).","journal-title":"Nat. Microbiol."},{"key":"44077_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D: Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D: Struct. Biol."},{"key":"44077_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D: Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D: Biol. Crystallogr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44077-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T11:05:18Z","timestamp":1702551918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44077-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44077"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-44077-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8302"}}